You just read:

European Hematology Association: Global Trial of the Efficacy and Safety of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma: An Interim Analysis of the JULIET Study

News provided by

European Hematology Association

Jun 24, 2017, 02:30 ET